Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Molecular Cloning of Leishmania major gp63 Gene in BALB/c Mouse CT26 Cell Line

Hossein Rezvan 1 , *
Author Information
1 Department of Laboratory Sciences, Faculty of Paraveterinary Sciences, Bu-Ali Sina University, Hamadan, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: May 28, 2015, 17 (5)
  • Published Online: May 31, 2015
  • Article Type: Research Article
  • Received: January 16, 2014
  • Accepted: April 5, 2014
  • DOI: 10.17795/zjrms958

To Cite: Rezvan H. Molecular Cloning of Leishmania major gp63 Gene in BALB/c Mouse CT26 Cell Line, Zahedan J Res Med Sci. 2015 ; 17(5):-. doi: 10.17795/zjrms958.

Copyright © 2015, Zahedan University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Royer MA, Crowe CO. American cutaneous leishmaniasis. Arch Pathol Lab Med. 2002; 126(4): 471-3[DOI][PubMed]
  • 2. TDR/WHO . Leishmaniasis. 2012;
  • 3. Griekspoor A, Sondorp E, Vos T. Cost-effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan. Health Policy Plan. 1999; 14(1): 70-6[PubMed]
  • 4. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004; 27(5): 305-18[DOI][PubMed]
  • 5. Kar K. Serodiagnosis of leishmaniasis. Crit Rev Microbiol. 1995; 21(2): 123-52[DOI][PubMed]
  • 6. Soto J, Rojas E, Guzman M, Verduguez A, Nena W, Maldonado M, et al. Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis. Clin Infect Dis. 2013; 56(9): 1255-60[DOI][PubMed]
  • 7. Zucca M, Scutera S, Savoia D. New chemotherapeutic strategies against malaria, leishmaniasis and trypanosomiases. Curr Med Chem. 2013; 20(4): 502-26[PubMed]
  • 8. Ali SA, Rezvan H, McArdle SE, Khodadadi A, Asteal FA, Rees RC. CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model. Parasite Immunol. 2009; 31(7): 373-83[DOI][PubMed]
  • 9. Maroof A, Brown N, Smith B, Hodgkinson MR, Maxwell A, Losch FO, et al. Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis. J Infect Dis. 2012; 205(5): 853-63[DOI][PubMed]
  • 10. Kedzierska K, Curtis JM, Valkenburg SA, Hatton LA, Kiu H, Doherty PC, et al. Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses. PLoS One. 2012; 7(3)[DOI][PubMed]
  • 11. Mayrink W, Mendonca-Mendes A, de Paula JC, Siqueira LM, Marrocos Sde R, Dias ES, et al. Cluster randomised trial to evaluate the effectiveness of a vaccine against cutaneous leishmaniasis in the Caratinga microregion, south-east Brazil. Trans R Soc Trop Med Hyg. 2013; 107(4): 212-9[DOI][PubMed]
  • 12. Armijos RX, Weigel MM, Aviles H, Maldonado R, Racines J. Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up. J Infect Dis. 1998; 177(5): 1352-7[PubMed]
  • 13. Khamesipour A, Rafati S, Davoudi N, Maboudi F, Modabber F. Leishmaniasis vaccine candidates for development: a global overview. Indian J Med Res. 2006; 123(3): 423-38[PubMed]
  • 14. Joshi PB, Sacks DL, Modi G, McMaster WR. Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63). Mol Microbiol. 1998; 27(3): 519-30[PubMed]
  • 15. Chaudhuri G, Chaudhuri M, Pan A, Chang KP. Surface acid proteinase (gp63) of Leishmania mexicana. A metalloenzyme capable of protecting liposome-encapsulated proteins from phagolysosomal degradation by macrophages. J Biol Chem. 1989; 264(13): 7483-9[PubMed]
  • 16. Seay MB, Heard PL, Chaudhuri G. Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes. Infect Immun. 1996; 64(12): 5129-37[PubMed]
  • 17. Arora SK, Pal NS, Mujtaba S. Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines. Exp Parasitol. 2005; 109(3): 163-70[DOI][PubMed]
  • 18. Soudi S, Hosseini AZ, Hashemi SM. Co-administration of rectal BCG and autoclaved Leishmania major induce protection in susceptible BALB/c mice. Parasite Immunol. 2011; 33(10): 561-71[PubMed]
  • 19. Ravindran R, Bhowmick S, Das A, Ali N. Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis. BMC Microbiol. 2010; 10: 181[DOI][PubMed]
  • 20. Farajnia S, Rahbarnia L, Maleki Zanjani B, Alimohammadian MH, Abdoli Oskoee S, Beh-Pajooh A, et al. molecular cloning and characterization of P4 nuclease from leishmania infantum. Enzyme Res. 2011; 2011: 970983[DOI][PubMed]
  • 21. Rasouli M, Zavaran Hoseini A, Kazemi B, Alborzi A, Kiany S. Expression of recombinant heat-shock protein 70 of MCAN/IR/96/LON-49, a tool for diagnosis and future vaccine research. Iran J Immunol. 2009; 6(2): 75-86[PubMed]
  • 22. Larreta R, Soto M, Alonso C, Requena JM. Leishmania infantum: gene cloning of the GRP94 homologue, its expression as recombinant protein, and analysis of antigenicity. Exp Parasitol. 2000; 96(2): 108-15[PubMed]
  • 23. Cheng J, Zhong Y, Liu Y, Yang J. Cloning and sequence analysis of an amastin coding gene from Leishmania major Abdou. Chin Med J (Engl). 1999; 112(8): 698-700[PubMed]
  • 24. Chen J, Si CW, Wang QH, Liu Y, Zhong YW, Yang JZ, et al. [Cloning and sequence analysis of a gene encoding amastin from Leishmania major]. Chinese. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2000; 18(1): 30-2[PubMed]
  • 25. Li JF, Chen JP, Tian Y, Yang ZW, Ma Y, Hu XS. [Cloning of avastin gene of leishmania donovani isolates from Sichuan Province and its expression in eucaryotic system]. Chinese. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2007; 25(2): 124-8[PubMed]
  • 26. Bhardwaj S, Vasishta RK, Arora SK. Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis. Exp Parasitol. 2009; 121(1): 29-37[DOI][PubMed]
  • 27. Mazumder S, Maji M, Ali N. Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection. PLoS Negl Trop Dis. 2011; 5(12)[DOI][PubMed]
  • 28. Mazumder S, Maji M, Das A, Ali N. Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice. PLoS One. 2011; 6(2)[DOI][PubMed]
  • 29. Rezvan H, Rees R, Ali S. Immunogenicity of MHC class I peptides derived from leishmania mexicana Gp63 in HLA-A2.1 transgenic (HHDII) and BALB/C mouse models. Iran J Parasitol. 2012; 7(4): 27-40[PubMed]
  • 30. Rezvan H. Immunogenicity of HLA-DR1 restricted peptides derived from Leishmania major gp63 using FVB/N-DR1 transgenic mouse model. Iran J Parasitol. 2013; 8(2): 273-9[PubMed]
  • 31. Rezvan H, Rees R, Ali S. Leishmania mexicana Gp63 cDNA using gne Gun induced higher immunity to L. mexicana infection compared to soluble Leishmania antigen in BALB/C. Iran J Parasitol. 2011; 6(4): 60-75[PubMed]
  • 32. Nagill R, Kaur S. Vaccine candidates for leishmaniasis: a review. Int Immunopharmacol. 2011; 11(10): 1464-88[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments